Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Clinical trial NCT06094842 · WITHDRAWN

Trial details

NCT number: NCT06094842
Sponsor: Fred Hutchinson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Carcinoma Prostate Small Cell Neuroendocrine Carcinoma Stage III Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2025-04-15
Primary completion: 2028-03-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.